Trial Profile
A study investigating the use of flutafuranol-F-18 in amyloid imaging in atypical/unclear dementia syndrome patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Flutafuranol F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 14 Oct 2015 New trial record